Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Artemis Therapeutics Inc (ATMS)

Artemis Therapeutics Inc (ATMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 55,793
  • Shares Outstanding, K 112,034
  • Annual Sales, $ 310 K
  • Annual Income, $ -1,360 K
  • 60-Month Beta -1.92
  • Price/Sales 680.85
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ATMS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings $-0.01 on 11/14/22
  • Latest Earnings Date 05/29/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2980 +67.11%
on 05/16/23
1.8900 -73.65%
on 05/19/23
+0.1991 (+66.61%)
since 04/20/23
3-Month
0.1121 +344.25%
on 04/17/23
1.8900 -73.65%
on 05/19/23
-0.9920 (-66.58%)
since 02/23/23
52-Week
0.1121 +344.25%
on 04/17/23
5.0000 -90.04%
on 05/31/22
-2.7020 (-84.44%)
since 05/25/22

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Artemis Therapeutics Inc. provides healthcare services. The company offers The Artemis Allergy Treatment Program for people suffering from seasonal, environmental or pet allergies. Artemis Therapeutics Inc., formerly known as New York Global Innovations Inc., is based in United States of America.

See More

Key Turning Points

3rd Resistance Point 0.4980
2nd Resistance Point 0.4980
1st Resistance Point 0.4980
Last Price 0.4980
1st Support Level 0.4980
2nd Support Level 0.4980
3rd Support Level 0.4980

See More

52-Week High 5.0000
Fibonacci 61.8% 3.1328
Fibonacci 50% 2.5561
Fibonacci 38.2% 1.9793
Last Price 0.4980
52-Week Low 0.1121

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar